Molecular alterations are an important factor when addressing treatment and may also influence the timing and risk of recurrence after complete (R0) resection in NSCLC. This study aimed to characterise recurrence-free survival (RFS) and recurrence dynamics in patients with EGFR-mutated and ALK-rearranged tumours.
Aguado et al. (Tue,) studied this question.